Searchable abstracts of presentations at key conferences in endocrinology

ea0026p137 | Male reproduction | ECE2011

Hypogonadism, insulin resistance and visceral adiposity in myotonic dystrophy

Passeri E , Bugiardini E , Sansone V , Fulceri C , Costa E , Ambrosi B , Meola G , Corbetta S

Hypogonadism occurs in myotonic dystrophy (DM) type 1 and 2, a multisystemic autosomal dominant disorder. DM patients have genetically induced insulin-resistance (IR) and visceral obesity, providing a model to study the impact of metabolic disruptions on hypogonadism. We assessed hypothalamic-pituitary-gonadal function and metabolic features in 22 DM1 and 8 DM2 males (mean±S.D., 46±11years). Hypogonadism, defined as total testosterone (T)<320 ng/dl...

ea0029p300 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Multiple cardiovascular risk factors in patients with myotonic dystrophy type 1 and 2

Passeri E. , Bugiardini E. , Sansone V. , Costa E. , Bandera F. , Pizzocaro A. , Meola G. , Ambrosi B. , Corbetta S.

Introduction: Myotonic dystrophy (DM) type 1 and 2 are multisystemic autosomal dominant disorders with visceral obesity, insulin resistance and hypogonadism. The prevalence of metabolic risk factors for coronary artery disease (CAD) in DM is not well defined, particularly in patients affected by DM2, a milder and clinical challenging condition.Methods: We assessed the frequency of CAD risk factors in 31 male DM1 (44±11 years) and 13 male DM2 (54&#17...

ea0041ep446 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Microbiological profile in diabetic foot infections: identification and susceptibility profile of bacteria isolated in 5 years in a Portuguese tertiary care hospital

de Sousa Lages Adriana , Oliveira Patricia , Costa e Silva Nuno , Guelho Daniela , Cardoso Luis , Vicente Nuno , Martins Diana , Oliveira Diana , Ventura Mara , Carrilho Francisco

Introduction: The diagnosis of infected ulcer is mainly clinical. The goals of the microbiological studies are identification of the pathogen and evaluation of susceptibility to antibiotics to minimize exposure to drugs and selection of resistant strains.Methods: Retrospective cohort study; Data collection: 1 January 2010 to 31 December 2014. Were included wound samples of aspirate, nonsurgical/surgical exudate, pus from abscesses and bone fragments from...

ea0029p806 | Endocrine tumours and neoplasia | ICEECE2012

Stem cell genes are deregulated in parathyroid tumours

Vaira V. , Verdelli C. , Forno I. , Elli F. , Guarnieri V. , Ferrero S. , Scillitani A. , Costa E. , Vicentini L. , Steffano G. , Cetani F. , Spada A. , Bosari S. , Corbetta S.

In our previous investigation on microRNAs expression pattern in parathyroid carcinomas (Ca), we detected the over-expression of microRNAs belonging to C19MC, the largest human cluster on chromosome 19q13.41. In the present study, the analysis of the expression of selected C19MC and the closely distal MIR371-3 clusters microRNAs (MIR512-3p, MIR517C, MIR520H and MIR372) was extended to 11 Ca, 24 adenomas (Ad) and 6 normal glands. The four microRNAs was expressed in 11% of parat...

ea0029p843 | Endocrine tumours and neoplasia | ICEECE2012

Tumour-asssociated myofibroblasts in parathyroid tumours

Verdelli C. , Avagliano L. , Meregalli M. , Guarnieri V. , Scillitani A. , Vicentini L. , Steffano G. , Costa E. , Torrente Y. , Spada A. , Bulfamante G. , Corbetta S.

Tumour-associated myofibroblasts are activated fibroblasts known to influence many aspects of tumour development. Parathyroid tumours show increased microvessels and atypical/malignant tumours are characterized by fibrous bands suggesting activation of the stromal cells. The aim of the present study was to investigate the role of myofibroblasts in parathyroid tumorigenesis. Human parathyroid tissues were analysed by specific immunostaining for the myofibroblast marker alpha-sm...

ea0029p1030 | Male Reproduction | ICEECE2012

Leydig and sertoli cell failure in myotonic dystrophy

Passeri E. , Bugiardini E. , Sansone V. , Fulceri C. , Costa E. , Bandera F. , Borgato S. , Persani L. , Pizzocaro A. , Meola G. , Ambrosi B. , Corbetta S.

Introduction: Hypogonadism occurs in myotonic dystrophy (DM) type 1 and 2, a multisystemic autosomal dominant disorder with insulin resistance and visceral obesity. DM patients provide a model to investigate the impact of metabolic alterations on hypogonadism.Methods: We assessed Leydig and Sertoli cell functions and metabolic features in 32 DM1 (44+11 years),13 DM2 patients (54+9 years) and 32 age and BMI-matched controls.Results:...